Rohini Chaudhari

  • Nurse Call Systems Market Projected to Gain Significant Value by 2027

    Transparency Market Research (TMR) has published a new report titled, ‘Nurse Call System Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global Nurse Call System Market was valued at US$ 1.27 Bn in 2018 and is projected to expand at a CAGR of 10.9% from 2019 to 2027.

    Planning To Lay Down Future Strategy? Request Brochure Of Nurse Call Systems Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2173

    Overview

    • The Nurse Calling System (NCS) is an innovative product to give reliable service to the patients. NCS ensures service guarantee to patients in the ward. Also, the wired and wireless models ease product installation in hospitals.
    • Nurse Call System is a nursing communication and management system using IP technology that can be used for both wired and wireless connections. The features of this system make it ideal for use in hospitals, homes, supervised apartments and day centers.
    • Global Nurse Call System Market segmented into Equipment Type, Communication Technology Type and End User. Equipment Type is segmented into Nurse Call Intercoms, Basic Audio, Digital Nurse Call system, IP Based and Nurse Call Mobile System. Communication Technology Type is segmented into Wireless and Wired systems. The End User is segmented into Hospital, Assisted Living Center, Nursing home and Clinics.
    • North America dominated the global Nurse Call System Market in 2018 and the trend is anticipated to continue during the forecast period. Highly structured health care industry, increased usage of emergency, and introduction of the Affordable Care Act in the U.S. are expected to drive the market in North America.
    • Asia Pacific is likely to be a highly lucrative market and it is expected to expand at a high CAGR during the forecast period.

    To Obtain All-Inclusive Information On Forecast Analysis Of Nurse Call Systems Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=2173

    Increasing need for efficient and responsive health care communication to Drive Market

    • Nursing staff need to be vigilant and responsive in order to ensure high quality of health care services and patient safety. With the help of nurse call systems, health care organizations are able to achieve seamless communication and streamlining of nursing activities. In addition, nurse call systems enable health care institutions to prioritize nursing calls based on the emergency and type of request registered by patients.
    • Nurse call systems have become increasingly important in supporting existing nursing staff in efficiently carrying out duties at assisted living centers and skilled nursing facilities. Such systems offer higher productivity and quality of nursing services in institutions which employ relatively new and inexperienced nurses.

    IP Based Segment to Dominate Market

    • Based on Equipment Type, the global Nurse Call System Market has been divided into Nurse Call Intercoms, Basic Audio, Digital Nurse Call system, IP Based and Nurse Call Mobile System.
    • The IP Based segment dominated the global Nurse Call System Market in 2018 and the trend is projected to continue during the forecast period. Increase in use of IP Based to accelerate the growth of the segment. Increase in the popularity of IP Based is also major factor for to boost the market growth.
    • IP based nurse call systems decrease the need for nurses to undertake routine checks on patients. Maintenance cost is also low. These are some of the factors driving the growth of the segment.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2173

    Wired segment to be Highly Lucrative Segment

    In terms of Communication Technology Type, the global Nurse Call System Market has been classified into Wireless and Wired.

    • The Wired segment dominated the Nurse Call System Market due to availability of cost effective (low cost).
    • The wired communication segment provides a safe, secure, and reliable communication network.
    • The segment drives the market owing to continued adoption of basic nurse call systems, including various audio and visual nurse call systems, which are basically wired communication in low-cost settings.

    North America to Dominate Global Market

    • In terms of region, the global Nurse Call System Market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global Nurse Call System Market in 2018, followed by Europe.
    • North America accounted for major share of the global Nurse Call System Market in 2018, owing to the growing demand for technological advanced systems and increasing need for higher efficiency and patient safety system in healthcare facilities.
    • The Nurse Call System Market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. This can be attributed to rapid economic growth in developing economies such as India, China, Indonesia, Vietnam, South Korea, and the Philippines. According to the United Nations ESCAP, the number of older people in the Asia Pacific region is expected to increase more than double from 547 million in 2016 to nearly 1.3 billion by 2050

    Competitive Landscape

    • The global Nurse Call System Market is fragmented in terms of number of players. Key players in the global market include Ascom Holding AG, Azure Healthcare Limited, Cornell Communications, Hill-Rom Holdings, Inc., Jeron Electronic Systems, Inc., STANLEY Healthcare, TekTone Sound & Signal Mfg., Inc., Tyco SimplexGrinnell, Vigil Health Solutions, Inc., Rauland-Borg Corporation (Acquired by Ametek, Inc.) and Honeywell International Inc. (Ackermann) among others

    More Trending Reports by Transparency Market Research –

    Diabetic Ulcers Treatment Market –

    https://www.prnewswire.com/news-releases/rising-complications-due-to-diabetes-is-pushing-adoption-of-diabetic-ulcers-treatment-market-valuation-will-rise-up-to-us13-6-bn-by-2026-end-finds-tmr-report-301016214.html

    Platelet Incubator Market –

    https://www.biospace.com/article/platelet-incubator-market-favorable-government-initiatives-to-promote-platelet-incubator-to-boost-growth/


  • Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market

    The global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market was valued at approximately US$ 2.9 Bn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 3.2% from 2017 to 2025, according to a new report published by Transparency Market Research titled “Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that rising incidence of the development of antibiotic resistant strains among all age groups are likely to spur the demand of MRSA Drugs in the coming years (2017 to 2025). As key players introduce novel anti-MRSA agents in developed markets such a North America and Europe, these regions are likely to account for dominating share of the global MRSA Drugs market. Established presence & wide distribution networks of major players and growing market penetration of emerging players are likely to boost growth of Asia Pacific MRSA Drugs market at a CAGR of around 3.7% from 2017 to 2025.

    Planning To Lay Down Future Strategy? Request Brochure Of Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1315

    Development of Treatment-Emergent Resistance in MRSA-Infected Patients to Restrain the Growth of MRSA Drugs

    According to CDC, around 33% of the people carry staphylococcus aureus, also known as staph, in their nose. But over the decades, few strains of staph such as MRSA (Methicillin-resistant Staphylococcus Aureus) have become resistant to some antibiotics that once destroyed it. MRSA strains are thus a type of staph that are resistant to beta-lactam antibiotic called methicillin. Around 1% of the population carrying staphylococcus aureus on their nose or skin are infected by MRSA. However, increased practice of prescribing antibiotics, 50% of which are unnecessary and inappropriate, is responsible to give rise to treatment-emergent resistance in MRSA-infected patients. According to the CDC, resistance to tigecycline and vancomycin, which are the effective and potent therapeutic options for severe MRSA infection, has emerged. Such treatment-emergent resistant strains developing in the MRSA-infected patients are expected to restrain the growth of MRSA drugs market during the forecast period.

    Lipopeptide drug class to lose the market share

    The report offers detailed segmentation of global MRSA drugs market on the basis of drug class, route of administration, and distribution channel. Among the drug class, lipopeptide is poised to account for leading share of the global market during the forecast period from 2017 to 2025. However, the segment is expected to lose its market share from 31.6% in 2016 to 30.5% by the end of 2025, owing to the loss of patent exclusivity for daptomycin in 2016, and emergence of generic drug molecules in lipopeptide drug class. Key pharmaceuticals companies such as Pfizer, Inc. involved in the manufacturing of oxazolidinones against MRSA infection, and their strong positioning in the global MRSA drugs market is likely to get boost the growth of oxazolidinone segment during the forecast period.

    To Obtain All-Inclusive Information On Forecast Analysis Of Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1315

    Oral to Be the Most Promising Route of Administration to Invest In

    Various route of administration offered in the report are oral and parenteral. Parenteral route of administration accounted for highest market share of 72.2% in 2016, due to the increased investment in the pharmaceutical sector by key antibiotics manufacturers to boost the production of intravenous anti-MRSA antibiotics. Oral route of administration is expected to get a boost in terms of revenue by 2025, which is attributable to the key companies involved in the R&D of anti-MRSA vaccines.

    Online Pharmacy to witness significant growth rate by 2025

    Rise in number of players in the antibiotic manufacturing industry, along with their widespread distribution channels are estimated to propel the market share of the retail pharmacy segment by 2025. Hospital pharmacy is expected to account for a market share of 51.0% by 2025, owing to the increased number of multispecialty hospitals across the globe, and their improved reimbursement policies. However, online pharmacy is likely to register highest CAGR of 3.4% during 2017-2025, due to rise in e-commerce sales, and improvement in digital sales channels to cater to the rising demand-supply gap for antibiotics.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1315

    Asia Pacific to Register Exponential Growth Rate and Offer Huge Incremental Opportunity

    Geographically, the global MRSA drugs market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2016, North America accounted for the highest market share in terms of revenue, which is attributable to the investments by U.S. based key players in the R&D of screening tools for MRSA infection. Europe is the second most prominent region in the global MRSA drugs market, which is projected to grow during the forecast period, due to research grants by the public & private players in the European countries to propel the R&D of anti-MRSA antibiotics. However, huge patient pool in the countries of China and India, and uncontrolled consumption of antibiotics in India are estimated to fuel the growth of MRSA drugs market in Asia Pacific with relatively significant CAGR of 3.7% during 2017-2025.

    Key Players such as Merck & Co., Inc., and Pfizer, Inc. are Likely to Continue to Lead the Global MRSA Drugs Market

    The prominent players operating in the global MRSA Drugs Market are Basilea Pharmaceutica Ltd., The Medicines Company, Theravance Biopharma, Allergan, Merck & Co., Inc., and Pfizer, Inc. Investing in the R&D and clinical trials of unique drug molecules in topical dosage form is the major strategy being adopted by key manufacturers to stay ahead in the rising competition.

    More Trending Reports by Transparency Market Research –

    Surgical Face Masks Market –

    https://www.prnewswire.com/news-releases/global-surgical-face-masks-market-to-grow-with-fundamental-changes-in-safety-manuals-of-hospitals-tmr-301067621.html

    Hematocrit Test Devices Market –

    https://www.biospace.com/article/hematocrit-test-devices-market-integrated-devices-to-open-new-opportunities-in-the-market/


  • Wearable Injectors Market to Reap Excessive Revenues by 2026

    A report by Transparency Market Research (TMR) throws light on the key dynamics operating within the global market for wearable injectors. The competitive landscape of the global market for wearable injectors has witnessed the entry of several newbie players over the past decade. This abrupt influx of new vendors can be attributed to the large market gap and lucrative growth opportunities floating in the global wearable injectors market. In order to counter the entry of new players, the established players in the global wearable injectors market have launched several schemes and strategies to attract the consumers.

    Mergers and acquisitions are projected to be a gold mine for the established market players who can expand their geographical reach by acquiring smaller players. Furthermore, non-price competition is also anticipated to be a key strategy of the larger market players over the forthcoming years. Hence, it is safe to prognosticate that the market vendors within the global wearable injectors market would tread along a path of economic stability over the forthcoming years.

    Planning To Lay Down Future Strategy? Request Brochure Of Wearable Injectors Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41969

    injectors is projected to expand at a stellar CAGR of 13.95 over the period between 2018 and 2026. The total market value stood at US$ 2,920.2 Mn in 2017 and is expected to reach an astral value of US$ 9,038.1 Mn by 2026. Based on geography, the market for wearable injectors in North America is expected to outdo all other regional segments. On the basis of end-use, diabetics are expected to be the largest consumers of these injectors.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=41969

    High Incidence of Chronic Diseases to Propel Demand

    The demand within the global market for wearable injectors has been escalating on account of the rising incidence of severe chronic diseases. Several patients are in dire need for continual administration of drugs in order to maintain their health, thus, necessitating the need for wearable injectors. The injection of insulin in diabetics is carried out through the use of wearable injectors, and this creates lucrative growth opportunities within the global market for wearable injectors. Treatment of diseases such as cancer, arthritis, psoriasis, and Crohn;s diseases also involves the use of wearable injectors.

    To Obtain All-Inclusive Information On Forecast Analysis Of Wearable Injectors Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=41969

    The inclination of the masses towards easier methods of drug injection has also le to the growth of the global market for wearable injectors. Furthermore, the rising geriatric population that is at a risk of suffering needle stick injuries also propels demand within the global wearable injectors market.

    Use of Traditional Methods to Hamper Growth

    Despite several advantages of wearable injectors, several hospitals and healthcare centers still prefer to use traditional methods for the injection of drugs or hormonal liquids. This has emerged as a huge roadblock for the growth of the global market for wearable injectors. Furthermore, the lack of skilled professionals who can inform and instruct the patients about the usage of wearable injectors also hampers the growth of the global market. However, the nascent developments in the healthcare industry and sophistication of medical procedures are expected to propel demand within the global market for wearable injectors.

    More Trending Reports by Transparency Market Research –

    Geriatric Medicines Market –

    https://www.prnewswire.co.uk/news-releases/rising-incidence-of-chronic-disorders-in-elderly-to-drive-demand-within-the-global-geriatric-medicines-market-tmr-891385678.html

    Cerebral Somatic Oximeters Market –

    https://www.biospace.com/article/cerebral-somatic-oximeters-market-is-projected-to-expand-at-a-cagr-of-7-2-percent-from-2018-to-2026/


  • Companion Animal Diagnostics Market to Garner Brimming Revenues by 2027

    Transparency Market Research (TMR) has published a new report on the companion animal diagnostics market for the forecast period of 2019–2027. According to the report, the global companion animal diagnostics market was valued at ~US$ 2.3 Bn in 2018 and is projected to expand at a CAGR of ~9% from 2019 to 2027.

    Global Companion Animal Diagnostics Market: Overview

    • Expansion of the global companion animal diagnostics market can be attributed to a rise in the incidence of obesity and other diseases in companion animals and increasing pet ownership.
    • North America dominated the global companion animal diagnostics market in 2018, and the trend is anticipated to continue during the forecast period. Highly structured healthcare industry, early new product adoption, and presence of major market players are expected to drive the market in North America.
    • Asia Pacific is expected to be a highly lucrative market for companion animal diagnostics, expanding at a high CAGR during the forecast period.

    Planning To Lay Down Future Strategy? Request Brochure Of Companion Animal Diagnostics Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=66719

    Clinical biochemistry to Dominate Companion Animal Diagnostics Market

    • The clinical biochemistry segment dominated the global companion animal diagnostics market in 2018, and the trend is likely to continue during the forecast period. Clinical biochemistry tests refer to blood tests or lab tests that help gain information about the health of the companion animal. Clinical biochemistry also includes glucose analysis, electrolyte analysis and others. Increasing demand and popularity of chemistry analyzers and glucose monitoring devices in disease diagnosis drives the segment. Moreover, the high preference for various advanced clinical diagnostic products by veterinarians, pet owners, and laboratory technicians is likely to fuel the clinical biochemistry segment in the next few years.

    Companion Animal Diagnostics Market: Clinical Pathology to Offer Lucrative Opportunities

    • In terms of application, the global companion animal diagnostics market is divided into clinical pathology, bacteriology, parasitology, and others.
    • The clinical pathology segment includes cytopathology, hematology, clinical chemistry, immunohematology, coagulation, urinalysis, endocrinology, and general pathology. The clinical pathology segment dominated the global companion animal diagnostics market due to a rise in the demand for diagnostic products and consumables needed to be used during pathology testing, and an increase the number of pathology tests performed on pets.
    • Bacteriology is estimated to be a highly lucrative segment of the companion animal diagnostics market during the forecast period. Bacteriology refers to the diagnosis of various bacterial diseases and infection in companion animals. Bacteriology tests include bacterial pathogens testing in blood or serum samples, and aerobic and anaerobic culture testing.

    To Obtain All-Inclusive Information On Forecast Analysis Of Companion Animal Diagnostics Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=66719

    Veterinary Reference Laboratories Account for Major Market Share

    • The veterinary reference laboratories segment dominated the global companion animal diagnostics market, in terms of revenue, in 2018. The trend is projected to continue during the forecast period. Increase in the number of veterinary reference laboratories across globe and availability of new advanced tests are likely to propel the segment. Furthermore, veterinary reference laboratories provide veterinary diagnostics to pet owners, and government-related programs or research collaborations are likely to boost the veterinary reference laboratories segment in the companion animal diagnostics market during the forecast period.
    • Veterinary hospitals and clinics is projected to be the second-most lucrative segment of the global companion animal diagnostics market during the forecast period. The segment is expected to expand at a significant CAGR from 2019 to 2027, as veterinary hospitals and clinics provide diverse veterinary diagnostic services for companion animals, and also provide advanced diagnosis testing.

    North America to Dominate Global Companion Animal Diagnostics Market

    • North America accounted for a major share of the global companion animal diagnostics market in 2018, owing to an increase in pet ownership, pet insurance, and presence of major manufacturers in the region. According to North American Pet Health Insurance Association (NAPHIA) reports, the total number of pets insured in the U.S. and Canada reached 2.43 million at year-end 2018, an increase of 17% from 2017.
    • The companion animal diagnostics market in Asia Pacific is likely to expand at a high CAGR from 2019 to 2027. This can be attributed to an increase in the number of companion animals in countries such as China and Japan, improvement of healthcare infrastructure in terms of better facilities, and a rise in the demand for advanced products in the region.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=66719

    Global Companion Animal Diagnostics Market: Competitive Landscape

    • The global companion animal diagnostics market is fragmented in terms of number of players. Key players operating in the global companion animal diagnostics market include Heska Corporation, IDEXX Laboratories, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., Zoetis, Inc., Neogen Corporation, bioMérieux SA, Randox Laboratories Ltd., and Virbac.

    More Trending Reports by Transparency Market Research –

    Sterilization Services Market –

    https://www.prnewswire.com/news-releases/outbreak-of-covid-19-to-boost-the-growth-of-global-sterilization-services-market-during-the-tenure-of-2019-to-2027-tmr-301062487.html

    Respiratory Disease Testing Market –

    https://www.biospace.com/article/respiratory-disease-testing-market-availability-of-basic-respiratory-devices-makes-hospitals-top-end-user/


  • Collagen Peptide and Gelatin Market Key Manufacturers, Development Trends and Competitive Analysis

    Transparency Market Research (TMR) has published a new report titled, “Collagen Peptide and Gelatin Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027”. According to the report, the global collagen peptide and gelatin market was valued at US$ 5,976.9 Mn in 2018 and is projected to expand at a CAGR of 8.7% from 2019 to 2027.

    Overview

    • Based on type, collagen peptide and gelatin are available in type I, type II and others
    • Rigorous research and development activities in regenerative medicine and wound healing and growth in commercialization of novel collagen-based drug delivery systems drive the market
    • North America dominated the global collagen peptide and gelatin market in 2018 and the trend is anticipated to continue during the forecast period. Presence of well-established collagen manufacturing facilities and use of advanced extraction methodologies are driving the market in the U.S.
    • Asia Pacific is expected to be a highly lucrative market for collagen peptide and gelatin, expanding at a higher CAGR during the forecast period

    Planning To Lay Down Future Strategy? Request Brochure Of Collagen Peptide and Gelatin Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1070

    Growth in Commercialization of Novel Collagen-Based Drug Delivery Systems, Rigorous Research and Development Activities in Regenerative Medicine and Wound Healing, and Increase in Social Awareness about Personal Well-Being Drive Market

    • Major factors driving the growth of nutraceuticals application segment are awareness, affordability, and accessibility. Nutraceuticals are used by the geriatric population and sportspersons, as these are a rich source of proteins and other essential supplements.
    • According to the European Nutraceutical Association (ENA), lack of nutrition accounted for 38.6% of the deaths in developing nations such as China, India, and Brazil. Thus, deficiencies due to nutrition are not related to the economic classes, but to the type of food consumed by the people.
    • Collagen sponges, shields, liposomes, microspheres, and nanoparticles constitute some of the collagen-based drug delivery products employed in various disease areas. Liposomes and nanoparticles constitute the novel forms of collagen-based drug delivery systems pertaining to sustained release. Furthermore, collagen is extensively used in encapsulation of active pharmaceutical ingredient (API) and render protection from disintegration in acidic gastric juices.

    To Obtain All-Inclusive Information On Forecast Analysis Of Collagen Peptide and Gelatin Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1070

    Type I Segment to Dominate Market

    • Based on type, the global collagen peptide and gelatin market has been divided into Type I, type II and others. Based on source, type I is further sub segmented into fish and others. Fish is further bifurcated into tilapia, carp, and others. Type II is segmented into hydrolyzed and undenatured.
    • The type I collagen held major share in the global collagen peptide and gelatin market in 2018 and is estimated to expand at the highest CAGR during the forecast period.
    • Increasing consciousness among people towards personal care and health has led to the rise in the use of nutraceuticals and cosmeceuticals. High demand for these products has led to the overall rise in the global collagen peptide and gelatin market as collagen is the main ingredient for these products owing to its anti-aging properties etc.

    North America to Dominate Global Market

    • Geographically, the global collagen peptide and gelatin market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global collagen peptide and gelatin market in 2018, followed by Europe.
    • North America accounted for major share of the global collagen peptide and gelatin market in 2018, owing to increasing R&D activities will result in development of novel drug formulations.
    • The collagen peptide and gelatin market in Asia Pacific is likely to expand at a higher CAGR from 2019 to 2027. Increasing geriatric population creates demand for collagen based bone substitutes, nutritional products, and other drug delivery systems.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1070

    Competitive Landscape

    • GELITA AG, Catalent, Inc., Rousselot, Nitta Gelatin, Inc., Capsugel Belgium NV, Amicogen, Inc. are the leading players in the global collagen peptide and gelatin market that hold majority of the market share
    • The global collagen peptide and gelatin market is fragmented in terms of number of players. Key players in the global market include Amicogen, Inc, BioCell Technology LLC, Capsugel Belgium NV, Catalent, Inc., ChinaTech Peptide Co., Ltd., GELITA AG, InterHealth Nutraceuticals, Inc, Nitta Gelatin, Inc., Norland Products, Inc., Rousselot.
    • New product development through robust R&D activities and merger & acquisitions are the key strategies adopted by these players to operate their business in the global collagen peptide and gelatin market

    More Trending Reports by Transparency Market Research –

    Culture Media Market –

    https://www.prnewswire.com/news-releases/culture-media-market-to-rise-at-7-7-cagr-during-2017-2025--launch-of-new-pharmaceuticals-to-drive-growth-says-tmr-300789727.html

    Compression Therapy Market –

    https://www.biospace.com/article/compression-therapy-market-increasing-obese-population-boost-market-growth/


  • Hearing Aids Market Key Insights, Profiling Companies and Growth Strategies

    A report by Transparency Market Research on the global hearing aids market states that the market has an oligopolistic landscape. The reason behind this is the dominance of just six prominent players. Cumulatively, these players accounted for 98% total growth of the market in 2015.

    This dominance of the players makes the entry of newcomers extremely difficult in the market. Even if a company manages to enter the market, it is at high risk of being overthrown by the incumbent players. Further, high initial investment is another factor that restricts a new player from entering the hearing aids market.

    The players who have a stronghold over the market are William Demant Holding Group, Widex A/S, Sonova Holding AG, Siemens Healthcare, Starkey, and GN ReSound.

    Planning To Lay Down Future Strategy? Request Brochure Of Hearing Aids Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4952

    Market: Major Growth Factor

    People with age above 50 have tendency to develop hearing problems. The report states that growing number of geriatric population in the U.S., India, China, and various European countries is purchasing hearing aids. Rise in sales of various hearing aids technologies in the regions is one of the major factors driving growth of the global hearing aids market from 2016 to 2024. Moreover, rising awareness of about variety of hearing aids available in the market among old people is also stimulating the growth of the market.

    4.5% CAGR from 2016 to 2024 in Multibillion-Dollar Market Indicates Enormous Prospects

    Transparency Market Research’s report suggests that the global hearing aids market is expected to witness 4.5% CAGR during the forecast period of 2016 to 2024. It also states that the market that worth US$ 4.7 bn in 2015 is expected to reach the value of US$7 bn by the end of 2024. The market is experiencing the projected growth, mainly on the back of rising hearing aid services provided by various companies that design and develop hearing aids products. Since deafness or hearing loss can happen at any age to anybody. Organizations are developing hearing aids devices which are accessible by every age group around the world. The development of products for various peoples of various ages is another factor driving the growth for the global hearing aids market. Additionally, better availability of the products to customers is also a prominent factor driving the growth of the market in the forecast period of 2016 to 2024.

    To Obtain All-Inclusive Information On Forecast Analysis Of Hearing Aids Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=4952

    Benefits from Support and Subsidy by Governments

    Governments across the globe are offering huge support to the companies that are developing hearing aid products. These governments are focused on preventing deafness in their respective countries. Subsequently they have introduced numerous initiatives to raise the awareness about the condition, products, and treatments. These initiatives stimulates the players to develop and unveil products to meet wide range of demands of populations.

    For instance, in 2017, president Trump signed Over the Counter (OTC) Hearing Aid Act which aims to improve the adoption of hearing aid devices for the patients lacking prescription of a healthcare practitioner. With this act the U.S. Government expects to support a large number of patients suffering from healing loss.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=4952

    Adult Hearing Aids Segment Held 95% of Market Share

    On the basis of end users, the global hearing aids market is bifurcated into two segments, the pediatric and adult hearing aids. Of these, the adult hearing aids segment is the largest shareholder in the global hearing aids market. According to the report, the segment accounts for 95% of total market share in 2015. This prominence of the segment is driven by the preference of the customer, affordability, flexibility of use, and low maintenance.

    More Trending Reports by Transparency Market Research –

    Prefilled Syringes Market -

    https://www.prnewswire.com/news-releases/prefilled-syringes-market-to-gain-us7-9-billion-by-2024-rising-demand-of-products-in-north-america-boosts-market-growth---tmr-300812365.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Anti-Snoring Devices and Snoring Surgery Market Will Escalate Rapidly in the Near Future

    The global anti-snoring devices and snoring surgery market depicts a fragmented competitive landscape. The small and large players of the market are focused on innovation to tap growth in the global anti snoring devices and snoring surgery market, states Transparency Market Research in a new market study. Predominantly, key players in the market are focused on to develop invasive treatment options such as implantable neurostimulation to increase their dominance in the global anti-snoring devices and snoring surgery market. Medtronic plc dominated the market share in 2015 followed by GE Healthcare and Philips. These companies collectively dominate the global anti-snoring devices and snoring surgery market with over 90% of market share

    According to a report by Transparency Market Research, the global anti-snoring devices and snoring surgery is likely to become US$22.7 billion by 2024. During the forecast period, the anti-snoring devices is expected to rise at a CAGR of 3.91% while anti-snoring surgery market is projected to rise at a 3.3% CAGR during the forecast period.

    Planning To Lay Down Future Strategy? Request Brochure Of Anti-Snoring Devices and Snoring Surgery Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6910

    Based on geography, Asia pacific is likely to dominate the regional anti-snoring devices and snoring surgery market. It is expected to increase at a CAGR of 5.09% from 2015 to 2024. This is mainly due to unhindered advertising campaigns in this region by product manufacturers to increase awareness about the condition. On the basis of device type, Mandibular Advancement Devices held the key share of the global anti-snoring devices and snoring surgery market.

    Increasing Prevalence of Obesity and Sleep Disorders to Rise Demand

    The rise in cases of obesity and sleep disorders across the globe is increasing the demand for snoring devices and snoring surgery. The increasing demand is encouraging key players to invest for technology advancements. The availability of technological advanced anti –snoring devices and advancements in surgery for snoring are propelling the global anti-snoring devices and snoring surgery market. Apart from this, the growing awareness among patients regarding the availability of effective treatment options is rising the global anti-snoring devices and snoring surgery market.

    To Obtain All-Inclusive Information On Forecast Analysis Of Anti-Snoring Devices and Snoring Surgery Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=6910

    High Price of Snoring Surgery to hinder growth

    One of the major restraints of the global anti-snoring devices and snoring surgery market is low patient compliance levels mainly due to the discomfort in using anti-snoring devices. Further, high cost associated with snoring surgery is likely to be an impediment to the growth of anti-snoring devices and surgery market. Nevertheless, increasing efforts of leading players for innovation is likely overcome restraints and offer lucrative avenue for the growth of the global anti-snoring devices and snoring surgery market.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=6910

    More Trending Reports by Transparency Market Research –

    Infusion Pumps Market –

    https://www.prnewswire.com/news-releases/infusion-pumps-market-to-attain-valuation-of-us-10-000-0-million-by-2026--favorable-government-policy-to-boost-market-growth-says-tmr-300791560.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Health Care Information Systems Market Analysis and Opportunity Assessment up to 2026

    Transparency Market Research (TMR) has published a new report titled ‘Healthcare Information Systems Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global health care information systems market was valued at US$ 227,021.4 Mn in 2017 and is projected to expand at a CAGR of 9.6% from 2018 to 2026. Increase in government initiatives and increase in adoption of health care IT products by health care providers are expected to boost the global health care information systems market from 2018 to 2026.

    North America is anticipated to dominate the global market during the forecast period owing rise in collaborations between companies for technological advancements, increase in government initiatives, and rise in private and public funding in health care information technology companies. For instance, in January 2017, Royal Philips and Banner Health entered into a multi-year partnership to innovate and expand on their successful joint connected health care programs such as the Intensive Ambulatory Care (IAC) pilot and Telehealth programs.

    Planning To Lay Down Future Strategy? Request Brochure Of Health Care Information Systems Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45612

    The market in Asia Pacific is expected to expand at a high CAGR during the forecast period. Expansion of the market is attributed to rise in incidence rate of chronic diseases, increase in geriatric population, and increasing government initiatives. For instance, in July 2016, Japan’s Ministry of Economy, Trade, and Industry announced plans to launch a demonstration project to improve diabetes management through the utilization of IoT and health information.

    Rise in Demand for Technologically Advanced Products to Drive the Market

    Advancements in health care information systems has led to significant growth of the market in the recent years. Use of health care information systems in medication management, electronic prescribing, intelligent wearable technologies to curb lifestyle diseases, and smart robots to automate repetitive tasks is expected to significantly reduce health care costs and boost the market. Adoption of IT products and solutions in health care as encouraged through government initiatives and increase in need to curtail escalating health care costs are further expected to propel the market during the forecast period.

    To Obtain All-Inclusive Information On Forecast Analysis Of Health Care Information Systems Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=45612

    Hospital Information Systems Segment Dominates the Market

    The report offers detailed segmentation of the global health care information systems market based on application, component, deployment, end-user, and region. In terms of application, the health care information systems market has been segmented into hospital information systems, pharmacy information systems, laboratory information systems, medical imaging information system, and revenue cycle management. The hospital information systems segment has been further divided into electronic health records, electronic medical records, real-time health care, patient engagement solutions, population health management, and others. The pharmacy information systems segment has been further categorized into prescription management, automated dispensing systems, inventory management, and others. The medical imaging information systems segment has been further split into radiology information systems (RIS), monitoring analysis software, picture archiving & communication systems (PACS), and others.

    Based on application, the hospital information system segment accounted for a prominent market share owing to a wide range of application of the systems, including automation of administrative, financial, and patient care activities of hospitals; production of extensive management reports and operational statistics; and a powerful query module. In addition, these systems provide benefits such as easy access to patient data, reduce scope of error, increase security, provide better cost control, and improve efficiency. This is likely to drive the segment during the forecast period. However, high implementation and maintenance cost present a constraint to the market. Based on deployment, the health care information systems market has been segmented into web based, on premise and cloud based. Based on component, the health care information systems market has been segmented into software, hardware and services. Based on end user the market is segmented into hospitals, diagnostics centre, academic and research institution and others.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=45612

    Significant Incremental Opportunity in the North America

    Based on region, the market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held a significant market share of the global health care information systems market in terms of revenue in 2017 due to high adoption of health care information systems in public and private hospitals, introduction of health care reforms, and technological advancements. In addition, government initiatives to promote usage of health care information systems in these regions are further anticipated to drive the market in the coming years. Europe accounted for a key share in the health care information systems market in 2017, in terms of revenue.

    Factors attributed to the expansion of the market in Europe are rise in patient population, advancement in diagnostic techniques, and increased adoption of health care information systems in various government organizations. The market in Asia Pacific is expected to expand at a prominent CAGR during the forecast period. Emerging markets in Asia Pacific hold immense expansion potential due to factors such as rise in prevalence of chronic diseases, increase in government initiatives, and increase in health care infrastructure. Moreover, adoption of new and sophisticated technologies, advances in diagnostic technologies, and increase in partnership of government with private players and clinical laboratories are likely to propel the market in the coming years.

    Market players operating in the health care information systems market include McKesson Corporation, GE Healthcare, Siemens Healthineers, Epic Systems Corporation, Allscripts Health Care Solutions, Inc., athenahealth, Inc., Agfa-Gevaert N.V., Cerner Corporation, NextGen Health Care Information Systems, LLC, and Medidata Solutions, Inc

    More Trending Reports by Transparency Market Research –

    Infusion Pumps Market –

    https://www.prnewswire.com/news-releases/infusion-pumps-market-to-attain-valuation-of-us-10-000-0-million-by-2026--favorable-government-policy-to-boost-market-growth-says-tmr-300791560.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Electrophysiology Devices Market Key Trends and Opportunity Analysis up to 2027

    The global electrophysiology devices market was valued at US$ 5,271 Mn in 2018. The global electrophysiology devices market is projected to register a cumulative annual growth rate (CAGR) of more than 8% from 2019 to 2027, according to a new report published by Transparency Market Research (TMR) titled, ‘Electrophysiology Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027′.

    Expansion of the healthcare industry, increase in healthcare expenditure, government initiatives, rise in product approvals, and increase in patient population are projected to augment the global electrophysiology devices market from 2019 to 2027. North America and Western Europe are likely to account for prominent shares in the global electrophysiology devices market, owing to the advancements in healthcare and products, and business expansion by various electrophysiology devices market leaders.

    Planning To Lay Down Future Strategy? Request Brochure Of Electrophysiology Devices Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=391

    Development of healthcare infrastructure and high medical expenditure by governments in emerging markets such as China and India are likely to boost the electrophysiology devices market in Asia Pacific at a CAGR of around 9.0% from 2019 to 2027.

    Rising Incidences of Cardiac Arrhythmias Expected to Propel the Electrophysiology Devices Market

    Arrhythmias is a major indication for the need of an electrophysiology examination. Globally, rising incidences of different types of arrhythmias, such as atrial fibrillation, atrial flutter, ventricular tachycardia, and atrial tachycardia, are playing key roles in boosting the electrophysiology devices market.

    The geriatric population, and people with high blood pressure, diabetes, obesity, and other cardiovascular diseases are at high risk of developing arrhythmias. This factor is likely to boost the electrophysiology devices market.

    • According to the National Center for Biotechnology Information (NCBI), Center for Disease Control and Prevention (CDC), and the ‘Sign Against Stroke in Atrial Fibrillation’ campaign, atrial fibrillation is a highly common arrhythmia, which affected more than 2.6 million people in the U.S., around 6 million in Europe, and nearly 8 million in China, in the year 2016.
    • It has been predicted that this toll is likely to increase 2.5 times by 2050, due to the influence of the globally rising geriatric population and changing lifestyle-related diseases. These factors are expected to boost the demand for electrophysiology devices at present, as well as in the near future.

    To Obtain All-Inclusive Information On Forecast Analysis Of Electrophysiology Devices Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=391

    Technological Advancements to Boost the Electrophysiology Devices Market

    Significant technological advancements in the field of electrophysiology devices have dramatically changed the way physicians treat their patients, leading to improved outcomes. Minimally invasive surgeries offer shorter hospital stay, minimal incision, less post-surgery complications, and shorter recovery time. Pacemaker lead is a major factor causing complications in patients implanted with pacemakers.

    • Nanostim, Inc. addressed this issue by producing a leadless pacemaker, the size of a pen tip, which is implanted with the help of a catheter. The introduction of other advanced electrophysiological products, such as MRI-compatible pacemakers, irrigated-tip catheters, 3D mapping systems, real-time digital Holter monitors, and steerable curve diagnostic catheters, has further enhanced the productivity of electrophysiology treatment, ultimately boosting the electrophysiological devices market.
    • Hence, increasing technological advancements and growing demand for minimally-invasive surgeries attract patients and help manufacturers increase patient throughput.

    Lack of Reimbursement Policies Restraining the Electrophysiology Devices Market

    • Electrophysiology devices are extensively utilized; however, there are no reimbursement policies for electrophysiology devices. This is a matter of concern, especially in developing countries where there are large patient pools that cannot afford electrophysiology devices.
      • Lack of reimbursement policies for a necessary devices, such as these, directly affects the sales of electrophysiology devices. For instance, the sales of Terumo Corporation’s micro guide catheters declined in Japan due to changes in the reimbursement policies concerning these catheters. Moreover, high volume of product recalls of Medtronic’s micro guide catheters in 2016 was a major setback for the global electrophysiology devices market.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=391

    Asia Pacific Market to Expand Significantly

    • The electrophysiology devices market in Asia Pacific is anticipated to expand at an impressive CAGR during the forecast period. The electrophysiology devices market in Asia Pacific is estimated to expand at a CAGR of around 9.0% during the forecast period. India, China, and Japan are expected to drive the electrophysiology devices market in Asia Pacific.
    • The increasing prevalence of cardiovascular diseases in countries such as India and China, increasing awareness regarding early diagnosis, and improving economic conditions are expected to fuel the electrophysiology devices market.

    Prominent Electrophysiology Devices Market Players – Biosense Webster, Inc., Abbott, Medtronic plc, and Boston Scientific Corporation

    The electrophysiology devices market report also provides the profiles of leading players operating in the global electrophysiology devices market. These include Biosense Webster, Inc., Abbott, Medtronic plc, and Boston Scientific Corporation. Increase in mergers & acquisitions, strategic collaborations, and new product launches are expected to drive the global electrophysiology devices market during the forecast period. Additionally, strong product portfolio, high brand recognition, and strong geographic presence are expected to boost the electrophysiology devices market during the forecast period.

    More Trending Reports by Transparency Market Research –

    Cardiac Surgery Instruments Market –

    https://www.prnewswire.com/news-releases/cardiac-surgery-instruments-market-to-hit-us1-412-7-million-with-increasing-threat-of-cardiovascular-diseases-says-tmr-300790695.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Endoprosthesis Market Growth Analysis up to 2026

    Endoprosthesis are mechanical devices that can be implanted in human skeleton, cardiovascular system, nervous system, and peripheral vascular system. Endoprosthesis is an artificial device used to replace bone, joints, and prosthesis. Additionally, it is used for teeth, femur, and hollow stent in vessels. Moreover, endoprosthesis provide support to other body parts lost due to a disorder or body disease, congenital defects, and accidents. Knee replacement is a major application of endoprosthesis. It is compatible with tissues and intended to be implanted into the body. The two types of endoprosthesis are cementless and cemented. Cementless endoprosthesis have a rough surface and are preferred in younger patients. Materials such as polyethylene, alloy metal, and ceramic are used to manufacture endoprosthesis.

    Report Overview @

    https://www.transparencymarketresearch.com/endoprosthesis-market.html

    Rise in prevalence of peripheral vascular diseases and orthopedic disorders are anticipated to drive the global endoprosthesis market. Moreover, increase in awareness among patients about usage of prosthetics in orthopedic injuries and rise in prevalence of knee & hip osteoarthritis among the geriatric population are projected to propel the global market during the forecast period. However, unfavorable reimbursement policies in middle and low income countries is expected to restrain the global endoprosthesis market. According to the Arthritis Foundation, arthritis is more common in women than men. According to the Centers for Disease Control and Prevention, 22.7% of adults in the U.S. had some form of arthritis between 2013 and 2015.

    Planning To Lay Down Future Strategy? Request Brochure Of Endoprosthesis Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=56208

    The global endoprosthesis market can be segmented based on product type, end-user, and region. In terms of product type, the market can be divided into biliary endoprosthetics, wall stent endoprosthetics, upper extremity prosthetics, dental prosthetics, and lower extremity prosthetics. The wall stent endoprosthetics segment can be classified into prosthetic aortic valves, prosthetic pulmonary valves, prosthetic mitral valves, and prosthetic tricuspid valves.

    Rise in prevalence of cardiac disorders is anticipated to drive the wall stent endoprosthetics segment. The upper extremities prosthetics segment can be categorized into hand prosthetics, elbow prosthetics, and shoulder prosthetics. The lower extremities prosthetics segment can be bifurcated into knee prosthetics and foot & ankle prosthetics. The knee prosthetics segment can be categorized into total rotational knee, total hinge knee, and total femur replace. Increase in incidence of orthopedic disorders drives the lower extremities segment. Rise in prevalence of periodontal disorders propels the dental prosthetics segment. In terms of end-user, the global endoprosthesis market can be classified into hospitals, clinics, and ambulatory surgical centers.

    To Obtain All-Inclusive Information On Forecast Analysis Of Endoprosthesis Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=56208

    The global endoprosthesis market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Rise in awareness among people about advanced technologies drives the endoprosthesis market in North America. According to the American Academy of Periodontology, half of the population of the U.S. suffers from periodontitis. Rise in prevalence of orthopedic disorders augments the endoprosthesis market in Europe. Improvement in health care infrastructure, surge in awareness about prosthetics in orthopedic injuries, and rise in prevalence of osteoarthritis among the geriatric population fuel the growth of the endoprosthesis market in Asia Pacific.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=56208

    The global endoprosthesis market is highly fragmented due to the presence of large number of global and local players. Key players operating in the global market are Zimmer Biomet, W. L. Gore & Associates, Boston Scientific Corporation, Acumed, LLC, Stryker, Wright Medical Technology, Inc., Smith & Nephew, BARD Peripheral Vascular, B. Braun Melsungen AG, and Allard USA, Inc.

    More Trending Reports by Transparency Market Research –

    Cardiac Surgery Instruments Market –

    https://www.prnewswire.com/news-releases/cardiac-surgery-instruments-market-to-hit-us1-412-7-million-with-increasing-threat-of-cardiovascular-diseases-says-tmr-300790695.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Clinical Oncology Next-generation Sequencing Market Growth Prospects, Trends and Forecast up to 2027

    Clinical Oncology Next Generation Sequencing: Introduction

    • Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy.

    Report Overview @

    https://www.transparencymarketresearch.com/clinical-oncology-next-generation-sequencing-market.html

    • Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15 minutes. In 2012, Ion Torrent had stated that their Ion Proton benchtop sequencer device could sequence an entire human genome in a day for less than US$ 1,000. In November 2019, Thermo Fisher Scientific launched its fully integrated next-generation sequencing (NGS) platform, Ion Torrent Genexus System, featuring an automated specimen-to-report workflow that delivers results economically in a single day.

    Planning To Lay Down Future Strategy? Request Brochure Of Clinical Oncology Next-generation Sequencing Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=74625

    Key Drivers and Restraints of Global Clinical Oncology Next Generation Sequencing Market

    • Rise in burden of cancer and its early diagnosis for treatment is fueling market growth. According to the 2018 GLOBOCAN database, the global cancer burden was predicted to rise to 18.1 million new cases, 9.6 million cancer deaths, and 43.8 million people living with cancer in 2018. Majority of cancer incidences occur in Asia and about one-quarter in Europe.
    • Increase in investments for oncology research is also driving the global clinical oncology next generation sequencing market. In 2019, Cancer Research UK invested US$ 262.90 Mn to focus on companies developing innovative oncology treatments. As per CB Insights, a research firm, equity investments in cancer-therapeutics startups grew from US$ 2 Bn in 2013 to US$ 4.5 Bn in 2017.
    • Non-value-based NGS reimbursement policy hampers market growth due to relatively high total costs of delivering NGS test results compared to other technology platforms, and limited coverage by payers

    To Obtain All-Inclusive Information On Forecast Analysis Of Clinical Oncology Next-generation Sequencing Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=74625

    Targeted Sequencing & Resequencing Technology for Skin Treatment to Witness High Demand

    • Based on technology, the global clinical oncology next generation sequencing market can be segmented into whole genome sequencing, whole exome sequencing, and targeted sequencing & resequencing
    • Targeted sequencing & resequencing segment dominates the clinical oncology next generation sequencing market, in terms of revenue generation. This technique is useful in analyzing specific mutations. Multiple genes can also be assessed across several samples in parallel. Due to its cost-effective findings, and accurate and easy-to-interpret results, targeted sequencing & resequencing holds a leading share of the global market. AmpliSeq offered by Illumina, Inc. is a comprehensive targeted resequencing solution, which can detect mutation in a few to hundreds of genes samples.
    • Whole genome sequencing segment is expected to grow significantly during the forecast period. Due to decrease in sequencing cost and expansion of computer resources, the whole genome sequencing technology will become common and sophisticated, as it provides sufficient information to understand the biology underlying the cancer genome and function of unexplored non?coding regions.

    Companion Diagnostic Segment to Witness Rapid Growth

    • Based on application, the global clinical oncology next generation sequencing market can be segregated into screening, companion diagnostics, and other diagnostics. Screening segment can be further divided into sporadic cancer and inherited cancer.
    • Demand for whole exome and genome sequencing tests is rapidly increasing for the screening of cancer to offer targeted diagnostic and treatment market for oncology. The next generation sequencing technology in the field of clinical oncology is applied in genetic diagnosis, cancer classification to prepare predictive biomarkers, and personalized medicine.
    • Companion diagnostic segment is expected to grow at a rapid rate due to numerous benefits offered by the technology in the field of oncology. In 2018, The Centers for Medicare & Medicaid Services (CMS) announced that it will pay for next generation sequencing (NGS)–based companion diagnostics for its beneficiaries with advanced cancer.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=74625

    North America to Dominate Global Market for Clinical Oncology Next Generation Sequencing

    • In terms of region, the global clinical oncology next generation sequencing market can be divided into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
    • North America holds the major share of the global market due to rise in government initiatives investments in researches, and presence of high-quality health care infrastructure. Furthermore, increase in incidences of cancer and high demand for personalized medicine are likely to boost the market in the region.
    • This market in Asia Pacific is projected to expand at a rapid CAGR during the forecast period, owing to the clinical oncology next generation sequencing market growth in emerging countries and continuous development in health care and pharmaceutical industries in the region. Countries with highest cancer rate includes Australia and New Zealand.

    Key Manufacturers Operating in Global Market

    The global clinical oncology next generation sequencing market was highly fragmented in 2018. Key manufacturers operating in the global market are:

    • Illumina, Inc.
    • F. Hoffmann-La Roche Ltd
    • Oxford Nanopore Technologies
    • Agilent Technologies
    • Thermo Fischer Scientific Inc.
    • PerkinElmer, Inc.
    • BD
    • Qiagen N.V.
    • Pacific Biosciences of California, Inc.
    • Takara Bio, Inc.
    • Creative Biolabs
    • Mogene LC

    More Trending Reports by Transparency Market Research –

    Veterinary Radiography System Market –

    http://www.prnewswire.com/news-releases/animal-health-gains-prominence-as-role-shifts-from-pets-to-companions-contributing-to-growth-in-veterinary-radiography-system-market-notes-tmr-301022155.html

    Polypill Products Market –

    https://www.biospace.com/article/polypill-products-market-demand-for-polypill-products-to-scale-new-heights-as-studies-focus-on-reducing-side-effects/


  • Donor Egg IVF (In-Vitro Fertilization) Market Key Opportunities and Forecast up to 2026

    Donor egg in vitro fertilization (IVF) is a process, wherein eggs are consensually borrowed from a donor, typically young woman (less than 33 years). The borrowed eggs from the donor are then fertilized using sperms of the recipient woman’s spouse. The resultant embryo is subsequently inserted in the recipient woman’s womb. The average success rate of this procedure ranges between 30% and 40%. Donor egg IVF can be performed on menopausal or elderly women, women patients suffering from severe endometriosis & tuberculosis, and those having major chromosomal defects. This procedure can also be performed in younger women who have undergone chemotherapy or radiation for cancer, women with prematurely failure of their ovaries, and also women who had undergone multiple-cycles of in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

    Report Overview @

    https://www.transparencymarketresearch.com/donor-egg-ivf-services-market.html

    Rise in prevalence of menopause across the world is projected to drive the global donor egg IVF services market. Most women reach menopause between 45 years and 55 years. According to American Congress of Obstetricians and Gynecologists estimates, 6,000 women in the U.S. reach menopause every day, which is approximately 2 million per year in the country alone. The number of elderly women is expected to rise exponentially in the next few years. The average global age of women at the time of menopause is 51 years. Moreover, rise in the female geriatric population is expected to increase the number of women with menopause across the world. Significant percentage of women with menopause experiencing difficulty in conceiving is likely to drive demand for services required for addressing these conditions during the forecast period.

    Planning To Lay Down Future Strategy? Request Brochure Of Donor Egg IVF (In-Vitro Fertilization) Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=53190

    Increase in the geriatric population is also anticipated to propel the global donor egg IVF services market during the forecast period. Elderly women generally find it difficult to conceive naturally due to loss of fertility. According to United Nations 2015 report, the number of people aged 60 years and above increased from 607 million in 2000 to 901 million in 2015. The geriatric population is expected to rise by 56% to 1.4 billion by 2030 and anticipated to increase two-fold from 901 million to about 2.1 billion by 2050. Women will account for significant proportion of the overall elderly population. Rise in the female geriatric population is anticipated to increase the number of individuals suffering from fertility issues. This in turn is expected to drive demand for egg donation IVF services.

    The global donor egg IVF services market can be segmented based on end-user, cycle type, and region. In terms of cycle type, the donor egg IVF services market can be classified into frozen donor egg IVF cycle and fresh donor egg IVF cycle. Based on end-user, the global donor egg IVF services market can be divided into hospitals, fertility clinics, and others

    To Obtain All-Inclusive Information On Forecast Analysis Of Donor Egg IVF (In-Vitro Fertilization) Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=53190

    In terms of region, the global donor egg IVF services market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global donor egg IVF services market in 2017 due to rise in geriatric population and high awareness level among the women population about these services in the region. The donor egg IVF services market in Asia Pacific is projected to expand at a high CAGR during the forecast owing to surge in fertility tourism and proliferation of fertility clinics in the region.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=53190

    Key players operating in the global donor egg IVF services market include Virtus Health, Flinders Reproductive Medicine Pty Ltd., Fairfax Egg Bank, Inc., and Fertility First.

    More Trending Reports by Transparency Market Research –

    E. coli Testing Market –

    http://www.prnewswire.com/news-releases/frequent-outbreaks-and-antibiotic-resistant-strains-driving-growth-in-e-coli-testing-market-states-tmr-301019737.html

    Psoriasis Treatment Market –

    https://www.biospace.com/article/psoriasis-treatment-market-predictive-biomarkers-offer-opportunities-in-specialised-medicine/


  • Platelet Rich Plasma (PRP) Market Opportunity Assessment and Forecast up to 2022

    The Europe PRP market is highly fragmented and competitive with the presence of a large number of small and large multinational players across the globe, says a Transparency Market Research (TMR).

    Some of the established players operating in the Europe platelet rich plasma market are Arthrex, Inc., Biomet, Inc., and EmCyte Corporation. Altogether, these three players have dominated the Europe PRP market in 2013. The market is witnessing entry of several new players as well. This is expected to intensify market completion in the coming years.

    The analyst of TMR, noted Europe platelet rich plasma market at US$42.1 mn in 2013. The market is expected to rise at a CAGR of 8.30% from 2014 to 2022. Rising at this CAGR, the market is predicted to attain a valuation of US$ 87.2 mn by the end of forecast period.

    Planning To Lay Down Future Strategy? Request Brochure Of Platelet Rich Plasma (PRP) Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4761

    On the basis of countries, the UK dominated the Europe platelet rich plasma market in 2013. The country is expected to continue its dominance during the forecast year as well. This is mainly because of the increasing prevalence of reconstructive and orthopedic procedures in the country. Based on application, the orthopedic surgery segment led the platelet rich plasma market. In the base year, the segment led the market with 38.3% of lion’s share. This is mainly due to the increasing geriatric population and the rising count of sports and orthopedic injuries in the region.

    Growing Adoption of Platelet-Rich Plasma to Drive Market

    The global platelet-rich plasma market is expected to garner an impressive CAGR over the forecast period. Rising incidences of sports injuries, growing use of platelet-rich plasma in various therapeutic areas, increasing number of androgenic alopecia patients, and rise in the prevalence of arthritis are the key factors attributed to offer a significant push to the platelet-rich plasma market.

    The use of platelet rich plasma therapy is tremendously increased after 2009 owing to the promising solution offer by them to the patients. The intense research and development by the key players has increased the application scope of therapeutic. Moreover, platelet rich plasma has minimum side effects on the patient. This is anticipated to increase the adoption for the platelet rich plasma therapies thereby fueling the Europe platelet rich plasma market.

    To Obtain All-Inclusive Information On Forecast Analysis Of Platelet Rich Plasma (PRP) Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=4761

    In addition, the rising inclination of people towards platelet rich plasma therapies to treat several sports injuries is another strong factor expected to offer a significant boost to the Europe platelet rich plasma market. Along with this, platelet rich plasmas is also used is wide range of cosmetic surgeries and hair regain therapies. This is expected to fuel the Europe platelet rich plasma market in the coming years.

    Increasing Incidence of Treatment failure to Impede Growth

    Despite of several drivers, growth of the Europe platelet rich plasma market is hindered by several factors. One of the most prominent restraints of the market is soaring costs of therapies and devices of platelet rich plasma therapeutics. Along with this, that immunity system of human body rejects injection of plasma thereby causing a treatment failure. This is expected to dampen the prospects of the Europe platelet rich plasma market during the forecast period.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=4761

    Nevertheless, factors such as launch of several advanced devices for platelet rich plasmas and the increasing awareness about platelet rich plasma therapy may offer lucrative opportunities to the growth of the Europe platelet rich plasma market.

    More Trending Reports by Transparency Market Research –

    Surgical Retractors Market –

    https://www.prnewswire.com/news-releases/increasing-geriatric-population-set-to-underscore-growth-in-global-surgical-retractors-market-from-2020-to-2030-tmr-301081728.html

    Sepsis Therapeutics Market –

    https://www.biospace.com/article/sepsis-therapeutics-market-immunometabolism-delivers-insights-on-new-therapeutic-targets/


  • Downstream Processing Market Size, Analysis and Forecast up to 2026

    Global Downstream Processing Market: Overview

    The exceptional development of the biotechnology industry has pushed the growth of global downstream processing market to new heights. Downstream processing finds extensive use in the biotechnology sector to isolate and purify biological products. The isolation of biological products has helped the pharmaceutical industry to make strides.

    Report Overview @

    https://www.transparencymarketresearch.com/downstream-processing-market.html

    The global downstream processing market could be studied on the basis of technique, application, end user, product, and region.

    The report serves to provide a brilliant analysis of the global downstream processing market. It analyzes vital aspects with a strong focus on market dynamics, market segmentation, and competitive scenario in the downstream processing market.

    Planning To Lay Down Future Strategy? Request Brochure Of Downstream Processing Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=58695

    Global Downstream Processing Market: Key Trends

    First and foremost, increasing demand for biosynthetic products for secondary application in pharmaceutics is the key factor driving the downstream processing market. At present, naturally sourced pharmaceuticals are increasingly witnessing demand due to their low risk of side-effects. Downstream processing enables recovery and purification of biosynthetic products from natural sources such as plant or animal tissue or fermentation broth. For example, downstream processing is a key step in the manufacture of antibiotics such as penicillin. The process involves purification and separation of antibiotics from a range of mediums.

    Downstream processing is applied in the commercial scale manufacture of monoclonal antibodies. Antibodies therapies generally involve long-term use of antibodies in substantial dose, because of which biopharmaceutical companies employ downstream processing for commercial scale production.

    Furthermore, downstream processing is employed in the commercial production of biological products. Some of these biological products are vaccines for small pox and influenza. Downstream processing is used in the industrial production of enzymes. These enzymes find applications in food preservation and food processing that have commercial value.

    To Obtain All-Inclusive Information On Forecast Analysis Of Downstream Processing Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=58695

    On the flip side, high cost of equipment for downstream processing and lack of trained personnel to conduct the process are limiting the growth of downstream processing market to some extent. In addition, purification bottleneck and lack of single-use options are some other factors challenging the downstream processing market.

    Global Downstream Processing Market: Geographical Analysis

    The global downstream processing market could be spread across North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. As per the report findings, North America and Europe are established markets for downstream processing. These regions being long-established centers of scientific research make them key regions for downstream processing.

    However, Asia Pacific is likely to present new growth opportunities to players in the downstream processing market. Factors such as increasing demand for biopharmaceuticals and increasing R&D initiatives in the biopharmaceutical industry are indirectly spurring the downstream processing market in the region.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=58695

    Global Downstream Processing Market: Competitive Analysis

    The report mentions and profiles key players operating in the global downstream processing market. Thermo Fisher Scientific Inc., Danaher Corporation, Boehringer Ingelheim, Sartorius Stedium Biotech S.A Eppendorf AG, GE Healthcare, Merck Millipore, 3M Company, Lonza Group, and Finesse Solutions Inc. are some top companies in the downstream processing market identified in this report.

    More Trending Reports by Transparency Market Research –

    Drug Discovery Outsourcing Market –

    https://www.prnewswire.com/news-releases/drug-discovery-outsourcing-market-to-clock-cagr-of-10--during-2020---2030-penetration-of-contract-research-organizations-keep-asia-pacific-highly-lucrative-market-notes-tmr-301077557.html

    Sterilization Services Market –

    https://www.biospace.com/article/sterilization-services-market-rise-in-number-of-hospital-acquired-infections-to-increase-demand/


  • Medical Drones Market Size will Observe Lucrative Surge by the End 2027

    Global Medical Drones Market: Introduction

    Medical Drones industry can be followed back to late 1800 and mid 1900 for military activities. At first drones were utilized to keep an eye on nations during cold war. The principal target drone was created somewhere around 1933 and 1935 at RAF Farnborough by consolidating fuselage with engine and wings.

    Report Overview @

    https://www.transparencymarketresearch.com/medical-drones-market.html

    Drones were likewise utilized in combat zone surveillance, anti-submarine warfare, and target practice. Uses of drones in medicinal sector were restricted until recent years. Right now, drones are being utilized in medical industry, yet the business is still in initial stage. They are utilized in providing emergency medications and blood products around 5 pounds in remote regions. In 2016, medical drones began providing essential meds and blood products in Rwanda helping individuals gaining awareness to biologics, that save life of individuals in emergency.

    Planning To Lay Down Future Strategy? Request Brochure Of Medical Drones Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=69870

    Global Medical Drones Market: Novel Developments

    • For example, in 2018, administration of Tanzania and DHL collaborated together to launch medical drone delivery program. Zipline is additionally attempting to provide and distribute blood, vaccinations, and life-saver drugs. Government’s primary target behind these activities is to spare existences of individuals by giving meds in the hour of need.
    • In 2016, medical drones began supplying important meds and blood product in Rwanda helping individuals.

    The major players operational in medical drones market are DJI, DHL, Embention, Matternet, Flirtey, Zipline, and Vayu. Industry players are executing systems, for example, growing distributional channels in undiscovered regions, coordinated efforts and new product launches to accumulate higher revenue share and continue in the business. For example, in April 2019, Zipline launched extension in drone delivery in Ghana. These drones will provide antibodies to remote zones. This initiative will help organization to grow its activity in Africa. The competition to highly intensify in future with increase in number of players.

    To Obtain All-Inclusive Information On Forecast Analysis Of Medical Drones Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=69870

    Quick Delivery of Medicines to Fuel Demand in Medical Drones Market Dynamics

    Developing uses of drones in medical sector will prove to be helpful for medical drones market development. Drones take into account critical needs of patients with the delivery of required vaccines, drugs, blood products, antivenin products in the various regions. Fast delivery encourages healthcare experts to provide treatment rapidly that could save patient’s life. In addition, they can provide drug to patient’s bedside that result in fewer mistakes in medicinal organization. Such wide scope of uses of drones will expand development of global medical drones market.

    Customarily, government policies have kept confinement over the use of drones to some extent. Nevertheless, various nations are currently accepting drones in healthcare and creating administrative strategies for utilization of drones. Government is embracing a various activities to create medical drones so as to provide services in specialty zones. Accordingly, industry should encounter lucrative scope of development in coming years.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=69870

    Germany to Lead Medical Drones Market Due to Several Government Initiatives

    In 2018, Germany medical drones market bagged the highest share of medical drones market. Noteworthy development can be ascribed to activities embraced by leading organizations. DHL, a logistic giant, based in Germany has introduced small drones that will provide medications to remote and coastal regions of nation. It has innovated an advanced drone that can take off without runway as well. Also, it has temperature-controlled capacity unit that provides medication at required temperature. Along these lines, developing utilization of medical drones in providing meds in Germany will demonstrate advantageous for market development.

    More Trending Reports by Transparency Market Research –

    Cardiac Arrest Treatment Market –

    https://www.prnewswire.com/news-releases/increasing-lifestyle-based-disorders-to-pave-way-for-strong-growth-of-global-cardiac-arrest-treatment-market-market-to-show-4-4-cagr-during-2019-to-2027--finds-tmr-301001793.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Vital Signs Monitoring Devices Market Demand, Insights and Forecast up to 2027

    Vital Signs Monitoring Systems Market: Introduction

    Transparency Market Research has published a new report titled, “Global Vital Signs Monitoring Systems Market”. According to the report, the global vital signs monitoring systems market was valued at ~US$ 7.4 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.

    Vital signs are indicators of the body’s ability to maintain homeostasis. Temperature, pulse, blood pressure, and respiration are considered to be vital signs because these are used to measure some of the body’s vital functions and provide information about a patient’s physical well-being. These also help in monitoring or detecting medical problems. Vital signs can be measured in medical emergency, home care settings, and medical settings. Vital signs monitors help to continuously measure multiple vital signs including temperature, ECG, non-invasive blood pressure, and SpO2. Wearable patch and watch are the recent innovations in vital signs monitoring system. Introduction of new products by key players is anticipated to drive the global vital signs monitoring systems market. For instance, in January 2017, Masimo launched the Rad-97 Pulse-CO Oximeter in India. Furthermore, growth of the global vital signs monitoring systems market can be attributed due to increase in number of patients with chronic cardiovascular and respiratory diseases. For instance, prevalence of COPD is increasing in countries such as India and others in Asia Pacific. An article published by Elsevier Ltd. stated that chronic respiratory diseases, COPD and asthma accounted for 10.9%, 8.7%, and 7.9% deaths, respectively, in India in 2016.

     

    Planning To Lay Down Future Strategy? Request Brochure Of Vital Signs Monitoring Devices Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2283

    North America dominated the global vital signs monitoring systems market in 2018 and the trend is anticipated to continue during the forecast period. Early adoption of technologically advanced products is likely to fuel the growth of the market in the region. The market in Asia Pacific is projected to expand at a strong CAGR from 2019 to 2027 owing to rise in prevalence chronic diseases due to changes in lifestyle and unhealthy diet. An article published in the International Journal of Chronic Obstructive Pulmonary Diseases stated that prevalence of COPD is higher in men than women in China and the estimated diagnosed rate of COPD varies from 23.61% to 30%.

    Easy Availability of Bench-top Products

    In terms of modality, the global vital signs monitoring systems market has been divided into bench-top, handheld, and wearable. The bench-top segment accounted for major share of the global vital signs monitoring systems market in 2018, owing to easy availability of products. The wearable segment accounted for significant share of the market in 2018. It is anticipated to grow at a rapid pace during the forecast period. Innovation in wearable medical technology is expected to drive the segment.

    To Obtain All-Inclusive Information On Forecast Analysis Of Vital Signs Monitoring Devices Market , Request A Discount

     

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=2283

    High Demand for Connected Devices-based Vital Signs Monitoring Systems

    Based on technology, the global vital signs monitoring systems market has been bifurcated into connected devices and conventional. The connected devices segment dominated the global vital signs monitoring systems market in 2018. In November 2016, Hill-Rom Services, Inc. announced that its subsidiary, Welch Allyn, entered into the connected home monitoring market along with Home Hypertension Program. The conventional segment accounted for significant share of the global vital signs monitoring systems market in 2018. Growth of the segment can be attributed to emergence of telemedicine.

     

    Consoles to Account for Major Share of Global Market

    In terms of component, the global vital signs monitoring systems market has been segmented into consoles, accessories & consumables, and apps/software. The consoles segment dominated the global vital signs monitoring systems market in 2018. The apps/software segment is likely to grow at a rapid pace during the forecast period owing to rise in use of Internet of Things in healthcare applications.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2283

    Rise in Prevalence of Cardiovascular Diseases to Fuel Market Growth

    Based on product, the global vital signs monitoring systems market has been divided into cardiovascular, blood pressure monitoring, body temperature, pulse oximetry, capnography, and respiratory rate. The cardiovascular segment has been bifurcated into ECG and heart rate. The cardiovascular segment dominated the global vital signs monitoring systems market in 2018. Rise in prevalence of cardiovascular diseases and reimbursement support for vital signs monitors are the factors projected to drive the segment. The ECG sub-segment accounted for major share of the cardiovascular segment in 2018. The sub-segment is anticipated to grow at a rapid pace during the forecast period. The pulse oximetry segment held significant share of the global vital signs monitoring systems market in 2018. The segment is expected to expand at a moderate CAGR from 2019 to 2027. The FDA approval for pulse oximeters offered by key players is likely to fuel the growth of the segment. In January 2019, Masimo received the FDA clearance for Rad-97 Pulse CO-Oximeter.

    Hospitals to be Major End User

    In terms of end user, the global vital signs monitoring systems market has been segmented into hospitals, home care, ambulatory surgical centers, and others. The hospitals segment dominated the global vital signs monitoring systems market in 2018 and the trend is projected to continue during the forecast period. Rise in rate of hospitalization for chronic diseases is anticipated to drive the segment.

    Vital Signs Monitoring Systems Market: Prominent Regions

     

    North America accounted for major share of the global vital signs monitoring systems market in 2018. Product launch & approvals and presence of key players are expected to boost the growth of the vital signs monitoring systems market in the region during the forecast period. In January 2018, Koninklijke Philips N.V. launched IntelliVue X3, next generation patient monitoring solution, in the U.S. IntelliVue X3 is a dual purpose monitor and highly portable with intuitive smartphone-style operation. Moreover, rise in prevalence of cardiovascular diseases is anticipated to fuel the growth of the vital signs monitoring systems market in North America. According to Canada Statistics, estimated incidence of high blood pressure is 90%, and hypertension affects almost 1 in 4 adults in Canada. In 2018, an estimated 5,360,000 people had high blood pressure in Canada.

    Europe held the second largest share of the global vital signs monitoring systems market in 2018. Growth of the market in the region is attributed to adoption of integrated technology and rise in prevalence of chronic diseases. In March 2017, Masimo announced the CE Mark for Rad-97 Pulse CO-Oximeter for non-invasive blood pressure measurement. According to the British Lung Foundation, an estimated 8,028,741 people were living with asthma in the U.K. in 2013.

     

    Asia Pacific held significant share of the global vital signs monitoring systems market in 2018. The market in the region is expected to grow at a rapid pace during the forecast period. Growth of the market in Asia Pacific is attributed to increase in the geriatric population. Moreover, surge in awareness about telemedicine is likely to accelerate the growth of the vital signs monitoring systems market in the region.

    Competitive Landscape

    Key players are expanding their footprint to strengthen their positions in the global vital signs monitoring systems market. For instance, in May 2017, Masimo announced partnership with Midmark Corporation to improve the efficiency and accuracy of vital signs monitors. This enabled the company to increase interaction of health care professionals and patients and enhance the outcomes at the point-of-care. Increase in focus of industry players on investment in developing regions to expand business is expected to augment the global vital signs monitoring systems market in the next few years.

    Prominent players operating in the global vital signs monitoring systems market are Medtronic, Welch Allyn (Hill-Rom Services Inc.), GE Healthcare (General Electric Company), Koninklijke Philips N.V., OMRON Corporation, VitalConnect, Infinium Medical, Masimo, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and BioBeat.


  • Industrial Microbiology Market Size to Expand Significantly by the End of 2024

    Global Industrial Microbiology Market: Overview

    The industrial microbiology market is large and growing owing to an increasing preference for automation. The rising emphasis on industrial food and safety is fueling the market’s grow. Industrial microbiology has applications in agriculture, cosmetics, food and beverages, and pharmaceuticals. Since the demand for consumer products is growing with the rise in the population worldwide, the need for product quality and safety testing is also on the rise. Various public concerns and government regulations regarding the safety of products are expected to continue to offer an opportunity for the market to grow.

    Industrial microbiology deals with the screening, improvement, and management of microorganisms for the production of various end use products. Fast and accurate testing of pathogens can protect brand image, reduce industry costs, and speed up the outbreak investigation and response. Increasing product recalls and growing consumer concerns are driving the global industrial microbiology market. The fermentation of beer, wine, and cheese also require industrial microorganisms, thus driving the market.

     

    Planning To Lay Down Future Strategy? Request Brochure Of Industrial Microbiology Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13727

    The report contains an overview of the industrial microbiology market, including its definition, key trends analysis, market dynamics, types of tests, and competitive landscape. The competitive landscape include the market positioning of key players and the competitive strategies adopted by them. The study segments the global industrial biology market on the basis of product type, test, application, and region. It includes Porter’s five forces analysis and market attractiveness analysis by countries.

     

    Global Industrial Microbiology Market: Key Opportunities and Threats

    The use of industrial microorganisms for syrup formulation, bioremediation process, preparing genetically modified food products, and manufacturing empty capsules will open new opportunities of growth in the market. On the other hand, maintaining compliance levels and lack of skilled professionals are major challenges faced by the industrial microbiology market.

     

    To Obtain All-Inclusive Information On Forecast Analysis Of Industrial Microbiology Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=13727

    Global Industrial Microbiology Market: Region-wise Outlook

    On the basis of geography, the global industrial microorganisms market is segmented into North America, Europe, Latin America, Asia Pacific, and the Rest of the World. North America is expected to be a key regional segment in the industrial microbiology market. The U.S. is expected to lead in the North America industrial microbiology market. Favorable reimbursements and patient policy and extensive drug research and development are behind the growth of the market in the U.S.

    Global Industrial Microbiology Market: Key Segments

    By product, the market is segmented into equipment and systems, reaction consumables, and laboratory supplies. The reaction consumables product type segment is expected to lead in the market owing to the high use of reagents and media for conducting various research.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=13727

    On the basis of application, the global industrial microbiology market is segmented into cosmetics, food and beverage industry, pharmaceutical, and agriculture. Of these, the pharmaceutical segment is expected to be a key revenue generator in the coming years. The growth in the segment is owing to the presence of a large number of pharmaceutical companies manufacturing and developing novel drugs. The frequency of drug innovation and speedy drug approvals are also behind the growth of the segment.

     

    Industrial Microbiology Market: Competitive Outlook

    Key players operating in the global industrial microbiology market include: 3M, Bio-Rad Laboratories, Inc., Merck KGaA, Danaher Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Asiagel Corporation, Eppendorf AG, bioMérieux SA, Novamed, QIAGEN, and Sartorius AG. The report profiles leading companies in the market and gives important information such as business and financial overview of each of the companies and their recent developments. The challenges faced by companies and the strategies adopted by them have also been included.

    More Trending Reports by Transparency Market Research –

    Portable Oxygen Concentrators Market –

    https://www.prnewswire.com/news-releases/high-prevalence-of-copd-driving-growth-in-portable-oxygen-concentrators-market-over-2018-2026-transparency-market-research-301005842.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Nicotine Replacement Therapy Market Projected to Gain Significant Value by 2026

    Cigarette smoking is a chronic health problem across the globe. There has been increased focus on the adverse economic and health effects of smoking. Tobacco contains nicotine which is addictive, and thus, tobacco smoking usually leads to nicotine addiction. Smoking cessation aids mainly include nicotine replacement therapy (NRT) products and drugs, which may be coupled with counselling and psychotherapy. However, certain nicotine withdrawal symptoms are observed during the process of smoking cessation, such as, anxiety and irritability, due to which the person, at times, is likely to start smoking again. The first line treatment for smoking cessation comprises either nicotine replacement therapy (NRT) products or drug therapy. However, lately, people willing to quit smoking are also seen preferring e-cigarettes to NRT products and drugs. E-cigarettes provide smokers with the same feeling as that of cigarettes; however, the former are known to aid in lowering nicotine addiction, though there has been a lot of debate about categorization of e-cigarette as a smoking cessation aid.

    Report Overview @

    https://www.transparencymarketresearch.com/nicotine-replacement-therapy-market.html

    Nicotine addiction is the second leading cause of death worldwide. According to the Centers for Disease Control and Prevention (CDC), around 44 million adults got addicted to cigarette smoking in 2011, with majority being from the low-income class in the U.S. Similar conditions prevail in other countries and pose an equal threat to human lives. Cigarette smoking is a primary cause of lung cancer and other respiratory and cardiac diseases. Awareness about these health hazards has encouraged smokers to adopt smoking cessation therapy.

     

    Planning To Lay Down Future Strategy? Request Brochure Of Nicotine Replacement Therapy Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54747

    Convincing results in the initial stages have motivated addicts to try NRT therapy. Smoking cessation campaigns have proved to be a key driver of the nicotine replacement therapy market. Government policies on raising taxes on cigarette products, ban on smoking in public places, and other such reforms have greatly influenced the nicotine replacement therapy market. According to the Tobacco Act in the Netherlands, smoking is banned in pubs, clubs, and restaurants. These acts have been implemented in order to curb smoking addiction as well as to help protect non-smokers from passive smoking. Other countries, including the U.S., the U.K., Germany, and Poland have implemented similar acts to restrict cigarette smoking. These events have driven cigarette addicts toward using NRT products. Introduction of new products is expected to boost the nicotine replacement therapy market, while providing more options to people willing to quit smoking. Currently available NRT products in the market are known to have certain side effects, which is a major reason for therapy dropout.

     

    The global nicotine replacement therapy market can be segmented on the basis of prominently used product type, distribution channel, and geography. The product type segment includes nicotine containing gums, patches, lozenges, sublingual tablets, inhalers, and mouth sprays, out of which, gums, patches, and lozenges generate maximum revenue. Based on distribution channel, the global nicotine replacement therapy market can be divided into hospital pharmacy, retail pharmacy, and online pharmacy.

    To Obtain All-Inclusive Information On Forecast Analysis Of Nicotine Replacement Therapy Market , Request A Discount

     

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=54747

    In terms of geography, the global nicotine replacement therapy market can be classified into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to be the leading market for nicotine replacement therapy, due to rising awareness against smoking hazards and high accessibility of nicotine replacement therapy products. Europe, the second leading market for nicotine replacement therapy, is expected to register double digit CAGR during the forecast period. Smoking restrictions, rising taxes on tobacco products, and mass media and school-based educational campaigns have helped curb the prevalence of smoking in Europe. Asia Pacific and Latin America are anticipated to record maximum growth in the near future as compared to the other regions. Demand for lifestyle drugs is witnessing rapid growth due to factors, such as, rise in health awareness, increase in population, and development of public health care systems, among others

    Key players operating in the global nicotine replacement therapy market include Cipla Ltd., GlaxoSmithKline plc, McNeil AB, NJOY, Inc., Novartis International AG, Pfizer, Inc., Revolymer PLC, and Takeda Pharmaceutical Co., Ltd.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=54747

    More Trending Reports by Transparency Market Research –

    Multiple Sclerosis Drugs Market –

    https://www.prnewswire.com/news-releases/consistent-efforts-to-find-effective-drugs-is-driving-growth-of-multiple-sclerosis-drugs-market-to-valuation-of-us-32-bn-by-2027-finds-tmr-301004337.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Canine Arthritis Treatment Market to Flourish with an Impressive CAGR by 2026

    Global Canine Arthritis Treatment Market: Overview

    Canine arthritis is a condition of pets that results in inflammation in joints and lead to a substantial increase in the inflammation due to lack of proper treatment. It commonly affects to the joints such as knee, elbow, shoulder, hip and spinal cord. There are various causes of canine arthritis in dogs such as accidental injuries, obesity, and failure in the bone development. Among all canine arthritis, the osteoarthritis is most common. One of the five adult dogs is suffering from osteoarthritis. This rising prevalence of the osteoarthritis is creating demand for its novel drugs. This is the key factor fuelling the growth of the global canine arthritis treatment market.

    Report Overview @

    https://www.transparencymarketresearch.com/canine-arthritis-treatment-market.html

    The report presents an in-depth study of the global canine arthritis treatment market which focuses on market dynamics, segmentation, and competitive analysis. The report offers useful guidelines to help key players and new entrants to hold a strong position in the canine arthritis treatment market. The report is the analysis and prediction of revenue mainly based on widespread primary and secondary research methodologies.

     

    Planning To Lay Down Future Strategy? Request Brochure Of Canine Arthritis Treatment Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=50910

    Global Canine Arthritis Treatment Market: Drivers and Restraints

    According to the American Pet Products Association, pet owners in the US spent more than US$7.4 bn, while pet owner in Europe spent near about US$6.1 bn on the vet care in 2017. This expenditure indicates the rising awareness about the health of the pet among the pet owners. This high awareness is fuelling adoption of the canine arthritis treatments and likely to propel the growth of the global canine arthritis treatments market. Additionally, rising prevalence of the diseases such as allergies, reduced energy, lower appetite, arthritis, lameness, dysplasia, and behavioral anxieties among dogs and cats globally increasing demand for the innovative therapies and drugs in order to withdraw symptoms of canine arthritis. This has surged the adoption of the canine arthritis treatments and likely to fuel the growth of the global canine arthritis treatment market.

     

    However, expensive treatments and possible side effects of the treatments are expected to hamper the growth of the global canine arthritis treatment market.

    To Obtain All-Inclusive Information On Forecast Analysis Of Canine Arthritis Treatment Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=50910

     

    Global Canine Arthritis Treatment Market: Geographical Analysis

    On the basis of region, the canine arthritis treatment market could be segmented into North America, South America, Europe, Asia Pacific, and the Middle East and Africa. Of these regions, in terms of value, North America is expected to dominate the global canine arthritis treatment market and continue its dominance over the forecast period. This growth is attributable to the higher consumption from countries like the US. According to the American Pet Products Association, the number of pet and expenditure on their health is higher in the US. Thus, the region is accounting for the higher revenue in the global canine arthritis treatment market. However, Europe and the Asia Pacific are expected to grow with higher CAGR over the forecast period. The factors such as growing disposable income and raising awareness about the pet health are leading to conduct higher growth in both the regions.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=50910

    Global Canine Arthritis Treatment Market: Companies Mentioned

     

    Some of the key players operating in the canine arthritis treatment market are Elanco (Eli Lily and Company), Ceva Santé Animale, Vetoquinol S.A., Norbrook Laboratories Limited, and Aratana Therapeutics Inc. From past few years, numerous key players have received approval for their new drugs or treatments, which is inspiring other key players to invest in the research and development (R&D) activities in order to develop the novel drugs and treatment on canine arthritis.

    More Trending Reports by Transparency Market Research –

    Lithotripsy Device Market –

    https://www.prnewswire.com/news-releases/increasing-prevalence-of-kidney-stones-to-drive-growth-of-global-lithotripsy-device-market-to-valuation-worth-us0-98-bn-by-2026-end-transparency-market-research-301003584.html.

    Osmometers Market –

    https://www.biospace.com/article/osmometers-market-north-america-leads-but-opportunities-abound-in-developing-countries/


  • Neuroscience Study Market to Reap Excessive Revenues by 2026

    Global Neuroscience Market: Overview

    The global neuroscience market is expected to witness a promising growth in the next few years. The rising level of competition among the leading players and the rising focus on the development of new products are likely to offer promising growth opportunities throughout the forecast period. The research study on the global neuroscience market offers a detailed overview, highlighting the key aspects that are expected to enhance the growth of the market in the near future. The key segmentation and the competitive landscape of the market have also been mentioned at length in the research study.

    Planning To Lay Down Future Strategy? Request Brochure Of Neuroscience Study Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=49641

    Global Neuroscience Market: Key Trends

    The rising trade of neuroscience consumables and devices for the diagnostics and imaging purpose of nervous system and brain is projected to encourage the growth of the global neuroscience market in the next few years. The function and structure of the nervous system and neurological disorders in several countries such as Russia and Poland is likely to enhance the growth of the overall market in the coming few years. Moreover, the rising awareness among consumers regarding to the benefits of advanced neuroscience devices, including combination of other imaging devices is projected to accelerate the growth of the global neuroscience market in the next few years.

    Global Neuroscience Market: Market Potential

    The rising government spending on the healthcare infrastructure, especially in developed regions is one of the major factors estimated to encourage the growth of the global neuroscience market in the next few years. The rising health spending in the U.S. is predicted to rise substantially, which is another key factor that is likely to enhance the market growth in the near future. In addition to this, the high adoption of new technologies and the rising spending on the research and development activities are expected to generate potential growth opportunities for the market players in the next few years.

    To Obtain All-Inclusive Information On Forecast Analysis Of Neuroscience Study Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=49641

    Global Neuroscience Market: Regional Outlook

    Among the key regional segments, the Middle East and Africa is expected to hold a large share of the global neuroscience market in the next few years. The rapid development of the medical sector is predicted to enhance the growth of the Middle East and Africa market for neuroscience in the coming few years. Furthermore, Asia Pacific is estimated to witness a healthy growth in the coming years. The rising geriatric population and the rising incidences of CNS disorders are predicted to encourage the growth of the market in the near future. Europe and North America are estimated to observe a promising growth in the next few years.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=49641

    Global Neuroscience Market: Competitive Analysis

    The global market for neuroscience is competitive in nature and is projected to witness a high level of competition among the key players in the next few years. The growing focus on the research and development activities and innovations is projected to support the growth of the overall market in the next few years. Moreover, the rising mergers and acquisitions and collaborations is likely to enhance the growth of the market in the near future. Some of the key players operating in the neuroscience market across the globe are Plexon Inc., Alpha Omega, Femtonics Ltd., Kendall Research Systems LLC, Doric Lenses Inc., Siemens Healthineers, GE Healthcare, Laserglow Technologies, Neuralynx, Thomas RECORDING GmbH, Mediso Ltd., TRIFOIL IMAGING, Prizmatix, and Neurotar.

    More Trending Reports by Transparency Market Research –

    Cardiac Arrest Treatment Market –

    https://www.prnewswire.com/news-releases/increasing-lifestyle-based-disorders-to-pave-way-for-strong-growth-of-global-cardiac-arrest-treatment-market-market-to-show-4-4-cagr-during-2019-to-2027--finds-tmr-301001793.html

    Hemostasis Valves Market –

    https://www.biospace.com/article/hemostasis-valves-market-stakeholders-innovate-on-hemostasis-valves-for-future-therapeutic-catheter-development-projects/


connect